Related Experiment Videos
[Nephropathies with HBsAg deposition in the kidneys]
Klinicheskaia Meditsina
|February 1, 1989
Insights
Hepatitis B surface antigen (HBsAg) deposition in kidneys occurred in 14 of 646 biopsies. This finding suggests HBsAg may be a risk factor for developing kidney disease, independent of blood detection.
Area of Science:
- Nephrology
- Hepatology
- Immunopathology
Background:
- Hepatitis B virus (HBV) infection is a global health concern.
- Kidney involvement in HBV infection can manifest as various forms of nephropathy.
- The role of Hepatitis B surface antigen (HBsAg) in renal pathology requires further elucidation.
Observation:
- A study analyzed 646 kidney biopsies for HBsAg deposition.
- HBsAg deposition was identified in the renal tissue of 14 patients.
- The clinical progression of kidney disease correlated with specific morphological changes.
Findings:
- There was no direct correlation between HBsAg presence in blood and kidney biopsy findings.
- Morphological variants of renal affection dictated the clinical course of nephropathy.
- HBsAg deposition in kidney tissue was observed in a subset of patients.
Implications:
- HBsAg deposition in the kidney may represent a distinct pathway for nephropathy development.
- Kidney biopsy is crucial for diagnosing HBsAg-associated nephropathy, irrespective of serological markers.
- These findings highlight HBsAg as a potential risk factor for renal disease.
Abstract:
Among the 646 kidney biopsies HBsAg deposition in the kidney was found in 14 cases. The clinical course of nephropathy was determined by the morphological variant of the affection. No parallelism was found between HBsAg discovery in the blood and kidney biopsy specimens. HBsAg can be a risk factor for nephropathy development.